Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

JENBURKT PHARMACEUTICALS LTD.

NSE : NABSE : 524731ISIN CODE : INE354A01013Industry : Pharmaceuticals & DrugsHouse : Private

BSE1065.1560.65 (+6.04 %)

PREV CLOSE ( ) 1004.50

OPEN PRICE ( ) 1024.80

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 5975

TODAY'S LOW / HIGH ( )1020.00 1130.00

52 WK LOW / HIGH ( ) 920.21410

NSE

This Company is not listed in NSE

Quarters

Select year

( in Million)

Particulars

Jun 2025

Mar 2025

Dec 2024

Sep 2024

Audited / UnAudited

UnAudited

Net Sales

355.27

410.47

368.93

412.16

Total Expenditure

265.69

301.9

280.72

297.9

PBIDT (Excl OI)

89.58

108.57

88.21

114.26

Other Income

20.57

18.8

15.82

18.53

Operating Profit

110.15

127.37

104.03

132.79

Interest

1.1

1.11

1.1

1.16

Exceptional Items

PBDT

109.05

126.26

102.93

131.63

Depreciation

7.22

7.91

7.79

6.39

Profit Before Tax

101.83

118.35

95.14

125.24

Tax

23.9

32.99

30.06

29.22

Provisions and contingencies

Profit After Tax

77.93

85.36

65.08

96.02

Extraordinary Items

Prior Period Expenses

Other Adjustments

0.00

Net Profit

77.93

85.36

65.08

96.02

Equity Capital

44.13

Face Value (IN RS)

Reserves

Calculated EPS

17.65

19.34

14.74

21.75

Calculated EPS (Annualised)

70.63

77.37

58.98

87.03

No of Public Share Holdings

2353750

2353210

2352850

2351940

% of Public Share Holdings

53.33

53.32

53.31

53.29

PBIDTM% (Excl OI)

25.21

26.45

23.90

27.72

PBIDTM%

31.00

31.03

28.19

32.21

PBDTM%

30.69

30.75

27.89

31.93

PBTM%

28.66

28.83

25.78

30.38

PATM%

21.93

20.79

17.64

23.29

Notes

Risk Disclosures on Derivatives

Quarterly Results

JENBURKT PHARMACEUTICALS LTD.